Please provide your email address to receive an email when new articles are posted on . Bone marrow aspirate concentrate injections may not provide benefit as an adjuvant for arthroscopic partial ...
Please provide your email address to receive an email when new articles are posted on . Cartilage repair with a hyaluronic acid-based scaffold and bone marrow aspirate concentrate may yield positive ...
BOCA RATON, Fla.--(BUSINESS WIRE)--SurGenTec, an innovative medical device company specializing in orthopedic and spine technology, is thrilled to announce that it has received 510(k) clearance from ...
The U.S. FDA granted Scopio Labs Ltd. de novo clearance for its artificial intelligence (AI)-powered software which analyzes bone marrow. Scopio’s Full-Field Bone Marrow Aspirate (FF-BMA) system aims ...
Israel-based Scopio Labs announced the FDA granted De Novo clearance for its Full-Field Bone Marrow Aspirate (FF-BMA) software that provides AI-enabled decision support tools for bone marrow analysis.
A novel 3D-printed scaffold for patient-specific partial breast reconstruction: A prospective, single-arm clinical trial. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This ...
AI-powered digital workflow brings greater consistency, efficiency, and collaboration to bone marrow morphologyCellaVision today announced the launch of the CellaVision® Bone Marrow Aspirate (BMA) ...
Researchers estimate that about 20% of patients who undergo anterior cruciate ligament (ACL) reconstruction will develop posttraumatic osteoarthritis (OA) within 10 years after surgery. That ...
SurGenTec, an innovative medical device company specializing in orthopedic and spine technology, is thrilled to announce that it has received 510(k) clearance from the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results